Hamilton Thorne, Inc. Announces 2012 Fourth Quarter and Year-End Financial Results

... cutting-edge embryo micromanipulation applications such as transgenic animal production, gene targeting, stem cell research and laser-assisted animal IVF. In July 2012, Hamilton Thorne commercially launched its IMSI-Strict imaging and analysis ...

http://www.biospace.com/news_story.aspx?StoryID=294855&full=1